Gene: TDRKH
Official Full Name: tudor and KH domain containingprovided by HGNC
Gene Summary: Predicted to enable RNA binding activity. Predicted to be involved in several processes, including P granule organization; male meiotic nuclear division; and piRNA processing. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31303 | TDRKH Knockout cell line (HeLa) | Human | TDRKH | 1:3~1:6 | Negative | Online Inquiry |
KO31304 | TDRKH Knockout cell line (HCT 116) | Human | TDRKH | 1:2~1:4 | Negative | Online Inquiry |
KO31305 | TDRKH Knockout cell line (HEK293) | Human | TDRKH | 1:3~1:6 | Negative | Online Inquiry |
KO31306 | TDRKH Knockout cell line (A549) | Human | TDRKH | 1:3~1:4 | Negative | Online Inquiry |
TDRKH Gene Knockout Cell Lines are specialized cellular models engineered to lack the expression of the TDRKH gene, which is integral in the regulation of various cellular processes, including RNA metabolism and gene expression. These knockout cell lines serve as invaluable tools in molecular biology and genetic research, allowing scientists to investigate the specific roles and downstream effects associated with the absence of TDRKH function.
The primary mechanism by which these cell lines operate is through targeted gene editing methodologies, such as CRISPR-Cas9, ensuring precise deletion of the TDRKH gene. This results in a cellular environment devoid of TDRKH, enabling researchers to assess changes in cellular pathways, gene interactions, and overall cellular behavior when TDRKH is not present. Such investigations can lead to a deeper understanding of its contributions to cellular processes and its involvement in various diseases.
In clinical and research settings, TDRKH Gene Knockout Cell Lines are crucial for elucidating gene function, drug discovery, and the development of gene therapies. They offer unique insights into the pathophysiology of diseases associated with dysregulated RNA metabolism, thus bridging the gap between basic research and therapeutic applications.
One of the standout advantages of these cell lines is their specificity and reproducibility compared to alternative models. Researchers are often faced with challenges when interpreting results due to off-target effects or incomplete gene knockdown in conventional studies. Our TDRKH Gene Knockout Cell Lines mitigate these concerns, providing a clean slate for studies that demand precise genetic manipulation.
The value of TDRKH Gene Knockout Cell Lines to researchers and clinicians lies in their potential to unlock critical pathways that may lead to novel therapeutic developments. Our commitment to quality and innovation is reflected in our extensive experience within the field, ensuring that our products meet the highest standards of scientific rigor and reliability. This dedication positions us as a trusted partner in advancing biotechnology research and therapeutic discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.